Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR Q Liu, C Xu, S Kirubakaran, X Zhang, W Hur, Y Liu, NP Kwiatkowski, ... Cancer research 73 (8), 2574-2586, 2013 | 239 | 2013 |
Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kinetics Q Liu, S Kirubakaran, W Hur, M Niepel, K Westover, CC Thoreen, J Wang, ... Journal of Biological Chemistry 287 (13), 9742-9752, 2012 | 130 | 2012 |
Triazole Inhibitors of Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase SK Maurya, DR Gollapalli, S Kirubakaran, M Zhang, CR Johnson, ... Journal of medicinal chemistry 52 (15), 4623-4630, 2009 | 111 | 2009 |
The structural basis of Cryptosporidium-specific IMP dehydrogenase inhibitor selectivity IS MacPherson, S Kirubakaran, SK Gorla, TV Riera, JA D’Aquino, ... Journal of the American Chemical Society 132 (4), 1230-1231, 2010 | 77 | 2010 |
Structure–activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH S Kirubakaran, SK Gorla, L Sharling, M Zhang, X Liu, SS Ray, ... Bioorganic & medicinal chemistry letters 22 (5), 1985-1988, 2012 | 60 | 2012 |
Facile one-pot synthesis of thio and selenourea derivatives: A new class of potent urease inhibitors K Sivapriya, P Suguna, A Banerjee, V Saravanan, DN Rao, ... Bioorganic & medicinal chemistry letters 17 (22), 6387-6391, 2007 | 50 | 2007 |
Experimental implementation of a three qubit quantum game with corrupt source using nuclear magnetic resonance quantum information processor A Mitra, K Sivapriya, A Kumar Journal of Magnetic Resonance 187 (2), 306-313, 2007 | 29 | 2007 |
Generation of phenothiazine with potent anti-TLK1 activity for prostate cancer therapy V Singh, S Bhoir, RV Chikhale, J Hussain, D Dwyer, RA Bryce, ... Iscience 23 (9), 2020 | 24 | 2020 |
Conformationally locked thiosugars as potent α-mannosidase inhibitors: synthesis, biochemical and docking studies K Sivapriya, S Hariharaputran, VL Suhas, N Chandra, S Chandrasekaran Bioorganic & medicinal chemistry 15 (17), 5659-5665, 2007 | 24 | 2007 |
Inhibitors of inosine 5′-monophosphate dehydrogenase as emerging new generation antimicrobial agents K Juvale, A Shaik, S Kirubakaran Medchemcomm 10 (8), 1290-1301, 2019 | 22 | 2019 |
High yield bacterial expression, purification and characterisation of bioactive Human Tousled-like Kinase 1B involved in cancer S Bhoir, A Shaik, V Thiruvenkatam, S Kirubakaran Scientific Reports 8 (1), 4796, 2018 | 21 | 2018 |
Evolution of PIKK family kinase inhibitors: A new age cancer therapeutics A Shaik, S Kirubakaran Frontiers in Bioscience-Landmark 25 (8), 1510-1537, 2020 | 20 | 2020 |
Compounds and methods for treating mammalian gastrointestinal microbial infections LK Hedstrom, GD Cuny, DR Gollapalli, B Striepen, SK Gorla, M Kavitha US Patent 8,969,342, 2015 | 17 | 2015 |
Novel cyclic tetraselenides of mannose: synthesis and mechanistic studies K Sivapriya, P Suguna, S Chandrasekaran Tetrahedron letters 48 (12), 2091-2095, 2007 | 16 | 2007 |
Rice husk filtrate as a nutrient medium for the growth of Desulfotomaculum nigrificans: characterisation and sulfate reduction studies E Chockalingam, K Sivapriya, S Subramanian, S Chandrasekaran Bioresource technology 96 (17), 1880-1888, 2005 | 16 | 2005 |
MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells N Singh, R Bhakuni, D Chhabria, S Kirubakaran BMC Research Notes 13, 1-9, 2020 | 15 | 2020 |
Exploring a solvated dimer of Gefitinib: a quantitative analysis D Angira, A Shaik, S Kirubakaran, V Thiruvenkatam Acta Crystallographica Section C: Structural Chemistry 74 (8), 944-950, 2018 | 14 | 2018 |
Novel chalcogenides of thymidine and uridine: synthesis, properties and applications K Sivapriya, P Suguna, S Shubashree, PR Sridhar, S Chandrasekaran Carbohydrate research 342 (9), 1151-1158, 2007 | 14 | 2007 |
New conformationally locked thioderivatives of mannose: synthesis, applications, and mechanistic studies K Sivapriya, S Chandrasekaran Carbohydrate research 341 (13), 2204-2210, 2006 | 14 | 2006 |
Targeting ATM and ATR for cancer therapeutics: Inhibitors in clinic B Priya, S Ravi, S Kirubakaran Drug Discovery Today 28 (8), 103662, 2023 | 12 | 2023 |